Evidence map›Paper›PMID 30318937›Full record

ReviewExpert review of medical devices2018

Principles of TAVR valve design, modelling, and testing.

Oren M Rotman, Matteo Bianchi, Ram P Ghosh, Brandon Kovarovic, Danny Bluestein

Abstract readReview
In one paragraph

Review in Expert review of medical devices, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Innovation and Challenges in Materials for Transcatheter Aortic Valves.Journal of cardiovascular translational research · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Oren M Rotmana Department of Biomedical Engineering , Stony Brook University , Stony Brook , NY , USA.
Matteo Bianchia Department of Biomedical Engineering , Stony Brook University , Stony Brook , NY , USA.
Ram P Ghosha Department of Biomedical Engineering , Stony Brook University , Stony Brook , NY , USA.
Brandon Kovarovica Department of Biomedical Engineering , Stony Brook University , Stony Brook , NY , USA.
Danny Bluesteina Department of Biomedical Engineering , Stony Brook University , Stony Brook , NY , USA.

Funding

Optimizing Cardiovascular Device Thromboresistance for Eliminating AnticoagulantsU01EB012487 · NIBIB · STATE UNIVERSITY NEW YORK STONY BROOK · PI BLUESTEIN, DANNY · 2010 to 2014
$6.9M
Optimizing Cardiovascular Devices Thrombogenicity for Eliminating AnticoagulationR01EB008004 · NIBIB · STATE UNIVERSITY NEW YORK STONY BROOK · PI BLUESTEIN, DANNY · 2007 to 2009
$1.7M
A Novel Polymeric Valve for Transcatheter Aortic Valve ReplacementR41HL134418 · NHLBI · POLYNOVA CARDIOVASCULAR, INC · PI BLUESTEIN, DANNY · 2017 to 2018
$225k
NHLBI NIH HHS R41 HL134418NIBIB NIH HHS R01 EB008004NIBIB NIH HHS U01 EB012487
6 · The paper itself

Abstract

introductionTranscatheter aortic valve replacement (TAVR) has emerged as an effective minimally-invasive alternative to surgical valve replacement in medium- to high-risk, elderly patients with calcific aortic valve disease and severe aortic stenosis. The rapid growth of the TAVR devices market has led to a high variety of designs, each aiming to address persistent complications associated with TAVR valves that may hamper the anticipated expansion of TAVR utility. AREAS COVERED: Here we outline the challenges and the technical demands that TAVR devices need to address for achieving the desired expansion, and review design aspects of selected, latest generation, TAVR valves of both clinically-used and investigational devices. We further review in detail some of the up-to-date modeling and testing approaches for TAVR, both computationally and experimentally, and additionally discuss those as complementary approaches to the ISO 5840-3 standard. A comprehensive survey of the prior and up-to-date literature was conducted to cover the most pertaining issues and challenges that TAVR technology faces. EXPERT COMMENTARY: The expansion of TAVR over SAVR and to new indications seems more promising than ever. With new challenges to come, new TAV design approaches, and materials used, are expected to emerge, and novel testing/modeling methods to be developed.

Indexed as

Prosthesis DesignTranscatheter Aortic Valve ReplacementAnimalsAortic ValveAortic Valve StenosisCalcinosisHeart Valve ProsthesisHumansOff-Label UsePolymersPolymersaortic stenosiscalcific aortic valve diseaseISO 5840medical deviceprosthetic heart valveTAVIthrombogenicityvalve hydrodynamics

Identifiers

PMID30318937
PMCPMC6417919

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.